Using Art Participation to Promote Psychosocial Health Among People With Physical Disabilities: A Feasibility Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Nethersole School of Nursing

About this trial

This study aims to explore the feasibility of a newly developed theory-based inclusive art participation program for promoting psychosocial health of people with physical disabilities living in residential care homes.

Specifically, the feasibility is assessed following the framework proposed by Bowen et al. (2009), which encompassed five aspects, including demand, implementation, practicality, preliminary effects, and acceptability. As for the preliminary effects, this project will evaluate self-esteem, sense of control, self-efficacy, mood, and social connectedness after the completion of program.

This study will adopt a one group pretest-posttest approach with quasi-experimental design to collect both quantitative and qualitative data, employing a mixed-methods study design.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged 18 years old or above

have single or multiple physical disabilities caused by disease, accident, or aging, characterized by long-term impairments in mobility, stamina, or dexterity

reside in residential care home

only have a mild cognitive impairment defined as having a Montreal Cognitive Assessment (MoCA) score which fall above the 16th percentile

Disqualifiers

individuals with severely impaired speaking, hearing, or visual acuity

individuals have physical unwell for participating in this study

individuals are currently taking part in other research projects or receiving other programs for promoting psychosocial health

Trial design

Design model

Single group

Treatments tested in this trial

  • Inclusive art program

    Other intervention

    The inclusive art participation program will consist of a six-weekly session syllabus of 90 minutes per session. It will be led by a nurse facilitator who has been trained in using art as a healing tool in the healthcare context. Group format of four to six participants per group will be adopted. It will be conducted in a private and active room at residential care homes, which offers a comfortable space that enables participants to express themselves in a safe and confidential environment. The program will focus not only on promoting psychosocial health but also emphasize the inclusive and supportive environment to contribute to social interaction and engagement in meaningful social activities, that affirm the rights of people with physical disabilities living in residential settings.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Art interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Preliminary effects - Sense of control

The Chinese version of Recovery Locus of Control Scale (RLOCS) 9-item will be adopted to assess sense of control. Each item is rated on a five-point scale from 1='strongly agree' to 5='strongly disagree'. The total score ranged from 9 to 45. A higher total score indicates a better sense of control.

Time frame
From enrollment to the end of treatment at 6 weeks.
2

Preliminary effects - Self-esteem

The Chinese version of Rosenberg Self-Esteem Scale - 10-item (RSES) will be adopted to measure self-esteem. It consists of five positively worded items and five negatively worded items. Each item is rated on a four-point scale. Specifically, positively worded items are given a score from 1='strongly agree' to 4='strongly disagree', while negatively worded are reverse scored, from 1='strongly disagree' to 4='strongly agree'. The total score is summed up to give a range from 10 to 40. A higher score represents greater self-esteem.

Time frame
From enrollment to the end of treatment at 6 weeks.
3

Preliminary effects - Self-efficacy

The Chinese version of General Self-Efficacy Scale (GSES) 10-item will be used to measure self-efficacy. Each item is rated on a four-point scale from 1='not at all true' to 4='exactly true'.The total score is summed up to give a range from 10 to 40. A higher score represents greater general self-efficacy.

Time frame
From enrollment to the end of treatment at 6 weeks.
4

Preliminary effects - Mood

The Chinese version of Positive and Negative Affect Scale (PANAS) will be used to evaluate mood. It is a 20-item self-report questionnaire that measures mood by assessing the experience of positive and negative emotions, which are 10 items for positive emotions and other 10 items for negative emotions. Each item is rated on a five-point scale from 1=' very slightly or not at all' to 5='extremely'. The total scores range from 10 to 50 for positive and negative mood, respectively. A higher score of positive domain indicates higher levels of positive affect, while a lower score of negative domain represents lower levels of negative affect.

Time frame
From enrollment to the end of treatment at 6 weeks.

Secondary outcomes

Other outcomes

1

Demand

Demand in this study refers to recruitment rate. Recruitment rate will be calculated by the following formula: the numbers of participant recruited in the program over the total numbers of potential participant approached.

Time frame
From enrollment to the end of treatment at 6 weeks.
2

Practicality

Practicality in this study means adverse events. Adverse events will be narratively recorded in a team-developed observation note sheet.

Time frame
From enrollment to the end of treatment at 6 weeks.
3

Implementation

Implementation in this study refers to attrition rate. Attrition rate will be calculated by the following formula: the numbers of participant dropped out of the study over the numbers of participant recruited in this study.

Time frame
From enrollment to the end of treatment at 6 weeks.
4

Acceptability

Acceptability in this study means participants' experiences and perspectives of engaging in the program. A team-developed interview guide will be adopted to collect such data.

Time frame
After the end of treatment at 6 weeks.

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: